Reply to "Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy"

Affiliations

• ¹ ALK-Abelló A/S, Hørsholm, Denmark.
• ² HICon, Capital Region, Denmark.
• ³ Division of Immunology and Allergy, Department of Pediatrics, Food allergy and Anaphylaxis Program, The Hospital for Sick Children, Toronto, ON, Canada.
• ⁴ Research Institute, The Hospital for Sick Children, Translational Medicine Program, Toronto, ON, Canada.
• ⁵ Department of Immunology, University of Toronto, Toronto, ON, Canada.
• ⁶ Papermill Medical, Copenhagen, Denmark.